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Background
Sarcoidosis is a multisystem disorder with cardiac invol-
vement in 25% of cases [1]. Diagnosis of cardiac sarcoi-
dosis is challenging with FDG-PET and cardiac MRI
(CMRI) proving most reliable. We compare FDG-PET
and CMRI with delayed enhancement (LGE) in patients
with biopsy proven extra-cardiac sarcoidosis being
investigated for cardiac involvement.
Methods
30 patients meeting Japanese Ministry of Health & Wel-
fare guidelines [2] for clinical cardiac sarcoidosis were
investigated with FDG-PET CT (Gemini TF Philips) and
CMRI (Aera 1.5T Siemens) on the same day. Patients
undergoing FDG-PET followed a 24 hour low-carbohy-
drate diet and overnight fast [3]. CMRI examination
included SSFP assessment of left ventricular (LV) func-
tion, short axis T2-weighted STIR and PSIR-LGE 10
minutes post 0.2 mmol/kg GdDTPA. Images were
reviewed by experienced readers blinded to the results
of the other examination. FDG-PET was considered
positive if any segment (AHA 17 segment model) had
an SUVmax > 3.6 (3). CMRI was considered positive if
any segment showed ‘sarcoid-type’ LGE. In no case was
edema present on STIR imaging without LGE in the
same segment on subsequent PSIR.
Results
FDG-PET and CMRI were positive in 10 patients; FDG-
PET +ve and CMRI -ve in 3; FDG-PET -ve and CMRI
+ve in 4; both -ve in 13. Distributions of FDG and LGE
throughout the myocardium are summarized in Figure
1. In 2 cases where FDG and CMRI were +ve, LGE was
in an ischemic pattern and both patients had known
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Figure 1 LV distribution of LGE (A) and significant myocardial FDG uptake (B) for all 30 patients. By both modalities, cardiac sarcoidosis
predominantly involves the lateral wall with relative sparing of the distal anterior wall, distal septum and apex.
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recent iscemic events (sub-endocardial). 6 of the
remaining 8 had impaired LV function (EF < 50%). All
FDG +ve/CMRI -ve cases had intense mediastinal/lung
FDG uptake. All 4 FDG -ve/CMRI +ve had either long-
standing sarcoidosis ( > 2 years) or absent node/lung
FDG activity. Seven of the cases, -ve by both modalities,
had no significant or minimal node/lung FDG uptake
(SUVmax < 2.5).
Conclusions
Previous single modality studies have suggested sensitivity
and specificity for FDG-PET of 89% and 78% and CMRI
of 75% and 77% respectively. In our study, 43% showed
no cardiac sarcoidosis by either modality and half of
these had minimal or no FDG-PET evidence of active
sarcoidosis elsewhere. Are these false -ve FDG-PET/
CMRI studies or are the clinical criteria too sensitive?
Our findings suggest FDG-PET and CMRI-LGE show dif-
ferent degrees of cardiac sarcoid involvement: FDG-PET
indicating active inflammatory disease, LGE showing
severe edema and scar. Those patients with LGE and no
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